Director of AI Engineering Pfizer R&D jobs in United States
cer-icon
Apply on Employer Site
company-logo

Pfizer · 10 hours ago

Director of AI Engineering Pfizer R&D

Pfizer is building an AI-first R&D engine to accelerate medicines to patients. As a Director of AI Engineering, you will work closely with scientists to develop AI systems that influence drug discovery and development processes.

BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
badNo H1Bnote

Responsibilities

Build AI that directly shapes R&D decisions Design, develop, and scale production-grade AI systems embedded in drug discovery and development programs—where model outputs inform choices on molecules, experiments, trials, and patient access to clinical trials
Own foundational and predictive modeling end-to-end From molecular optimization and experimental design to clinical trial simulation, patient stratification, and operational forecasting—take ideas from concept through validation, deployment, and measurable value
Advance generative AI for drug design Apply state-of-the-art generative approaches to molecular and protein engineering. Prototype quickly, evaluate rigorously, and deploy responsibly in high-stakes scientific contexts
Engineer elegant, reliable ML systems Architect robust pipelines with modern MLOps: cloud and HPC environments, distributed training, reproducibility, governance, and observability—designed for scientific credibility and operational scale. Automate and standardize the entire lifecycle of ML systems, from initial development to long-term production maintenance, providing compliance and an audit trails
Decode high-dimensional biology Integrate multimodal data—omics, imaging, real-world evidence, and scientific literature—into representations that surface biological insight and guide experimental and clinical strategy
Influence portfolio and strategy decisions Partner with scientific and strategy leaders to model uncertainty, run scenario analyses, and optimize resource allocation across a complex R&D portfolio
Stay at the frontier Continuously assess emerging AI methods and tools, translating advances into practical, defensible applications for a specific R&D discipline
Raise AI fluency across the organization Mentor scientists and engineers, foster hands-on curiosity, and help build a culture where rigorous experimentation and learning are the norm
Represent the science externally Publish, present, and engage with the broader AI and life-sciences community at leading conferences and forums

Qualification

AI EngineeringPredictive ModelingGenerative AIMachine Learning SystemsPythonCloud EnvironmentsHPC EnvironmentsScientific CommunicationIntellectual CuriosityMission-Driven MindsetCollaboration

Required

PhD or Master's in Computer Science, Machine Learning, Computational Biology, Software Engineering, AI, or a related discipline
AI native
2–5 years of applied AI/ML experience
Comfort operating across disciplines—chemistry, biology, pharmacology, statistics—with the ability to ground models in biological and clinical reality
Demonstrated expertise in predictive modeling, generative AI, and ML system design
Strong programming skills in Python and modern ML frameworks (e.g., PyTorch, TensorFlow), plus experience scaling models in cloud and/or HPC environments
Proven ability to collaborate with other scientists, and could include laboratory bench researchers, clinicians, product teams, and business leaders
Clear scientific communication, intellectual curiosity, and a mission-driven mindset focused on improving patient outcomes

Preferred

Experience in life sciences preferred, but not required (pharma, biotech, or health tech)
A working understanding of R&D workflows is preferred but not required, across target identification, lead optimization, translational science, clinical design, operations forecasting, or portfolio analytics

Benefits

Relocation assistance may be available based on business needs and/or eligibility.

Company

Pfizer is a biopharmaceutical company that discovers, develops, and delivers medicines and vaccines.

Funding

Current Stage
Public Company
Total Funding
$38B
Key Investors
Starboard Value
2025-11-21Post Ipo Debt· $6B
2024-10-07Post Ipo Equity· $1B
2023-05-16Post Ipo Debt· $31B

Leadership Team

leader-logo
Albert Bourla
Chief Executive Officer
linkedin
leader-logo
Ian Read
Chief Executive Officer
linkedin
Company data provided by crunchbase